← Back to headlines
Major Pharma Giants Back Owkin AI to Accelerate Drug Discovery
Bloomberg reports that AstraZeneca, Sanofi, and Boehringer Ingelheim are investing in Owkin's AI platform to overcome bottlenecks in pharmaceutical research and rapidly generate drug candidates.
3 Sept, 10:29 — 3 Sept, 10:29
Sources
Showing 1 of 1 sources
